Abstract | BACKGROUND: METHODS: Three patients with COVID-19 in this study were laboratory confirmed to be positive for SARS-CoV-2, with radiographic and clinical features of pneumonia. CP was collected by total IgG titer of 160 (range, 200-225 mL), and patients were transfused between 20 and 30 days after disease onset at the critical illness stage as a trial in addition to standard care. The clinical courses of these patients, including laboratory results and pulmonary functional and image studies after receiving convalescent plasma infusions, were reviewed. RESULTS: CONCLUSIONS:
|
Authors | Miao Liu, Zhen Chen, Meng-Yuan Dai, Jun-Hui Yang, Xiao-Bing Chen, Di Chen, Hua You, Xin Guo, Yan Leng, Li Yu, Meng-Li Zhang, Xian Wu, Junyu Yang, Chong Gao, Daniel G Tenen, Li Chai, Fen Ai |
Journal | Transfusion
(Transfusion)
Vol. 60
Issue 10
Pg. 2210-2216
(10 2020)
ISSN: 1537-2995 [Electronic] United States |
PMID | 32770691
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 AABB. |
Chemical References |
- Antibodies, Neutralizing
- Antibodies, Viral
- Immunoglobulin G
|
Topics |
- Antibodies, Neutralizing
(immunology)
- Antibodies, Viral
(immunology)
- COVID-19
(therapy)
- Critical Illness
- Humans
- Immunization, Passive
(methods)
- Immunoglobulin G
(immunology)
- Pneumonia
(immunology, virology)
- SARS-CoV-2
(pathogenicity)
- COVID-19 Serotherapy
|